Welcome to my home page. I am a registered pharmacist and worked in practice for 10 years prior to joining the staff at the University in 2008. I am interested in the clinical use of medicines, and my predominant teaching role is in the pharmacotherapeutics subjects of the 3rd year of the Undergraduate Pharmacy Program.
My primary research interests are personalised medicine (including pharmacogenomics and drug concentration effect relationships, particularly in patients with rheumatoid arthritis), drug allergy and deprescribing (the process of ceasing redundant medications).
About me
Welcome to my home page. I am a registered pharmacist and worked in practice for 10 years prior to joining the staff at the University in 2008. I am interested in the clinical use of medicines, and my predominant teaching role is in the pharmacotherapeutics subjects of the 3rd year of the Undergraduate Pharmacy Program.
My primary research interests are personalised medicine (including pharmacogenomics and drug concentration effect relationships, particularly in patients with rheumatoid arthritis), drug allergy and deprescribing (the process of ceasing redundant medications).
About me
About me
Doctor of Philosophy University of South Australia
Masters of Clinical Pharmacy University of South Australia
Bachelor of Pharmacy University of South Australia
Research
Excludes commercial-in-confidence projects.
Translational Venom and Antivenom Research, NHMRC - Centre of Research Excellence, 01/12/2015 - 30/11/2020
Optimisation of the safety and efficacy of protein kinase inhibitors using endogenous and dietary biomarkers, NHMRC - Project Grant, 01/01/2016 - 31/12/2018
Determinants of methotrexate disposition in rheumatoid arthritis, Central Adelaide Local Health Network Incorporated, 01/08/2013 - 31/07/2016
Identification of factors that influence efficacy and toxicity with leflunomide in the treatment of rheumatoid arthritis, Arthritis Australia, 01/01/2014 - 30/09/2015
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2020 |
Open access
|
2020 |
|
2020 |
2
1
2
|
2020 |
Open access
6
|
2020 |
|
2020 |
|
2020 |
1
2
|
2020 |
6
|
2020 |
Open access
1
1
|
2020 |
Open access
1
1
5
|
2020 |
2
|
2020 |
2
2
|
2019 |
Open access
4
4
10
|
2019 |
1
1
|
2019 |
Open access
8
7
3
|
2019 |
Open access
3
3
1
|
2019 |
1
1
|
2018 |
Open access
4
3
4
|
2018 |
Open access
23
19
65
|
2018 |
6
5
1
|
2018 |
7
6
1
|
2018 |
5
4
|
2017 |
10
10
3
|
2017 |
Open access
5
4
|
2017 |
Open access
73
78
8
|
2017 |
2
2
|
2017 |
Open access
16
15
|
2017 |
3
4
|
2017 |
31
29
2
|
2017 |
2
2
6
|
2017 |
8
10
1
|
2017 |
4
5
|
2017 |
3
3
|
2017 |
3
3
|
2017 |
61
59
41
|
2017 |
14
15
4
|
2016 |
Open access
8
3
1
|
2016 |
Open access
6
9
|
2016 |
Open access
7
1
|
2016 |
18
17
2
|
2016 |
1
1
|
2016 |
9
7
16
|
2016 |
7
5
|
2016 |
2
2
10
|
2016 |
7
7
4
|
2016 |
Open access
38
41
6
|
2016 |
Open access
48
54
35
|
2016 |
Open access
|
2015 |
Open access
9
9
|
2015 |
Open access
8
12
|
2015 |
Open access
9
8
|
2015 |
52
37
8
|
2015 |
48
49
3
|
2015 |
Open access
172
158
16
|
2015 |
Open access
285
276
15
|
2015 |
Open access
16
18
|
2015 |
21
21
5
|
2015 |
16
25
4
|
2014 |
6
5
1
|
2014 |
6
6
1
|
2014 |
50
44
8
|
2014 |
Open access
138
127
47
|
2014 |
Open access
57
39
7
|
2014 |
6
7
1
|
2014 |
Open access
61
66
1
|
2014 |
Open access
28
22
8
|
2014 |
19
17
|
2014 |
2
2
7
|
2014 |
37
36
10
|
2014 |
28
28
5
|
2014 |
Open access
5
4
|
2013 |
Open access
35
32
1
|
2013 |
50
44
|
2013 |
Open access
217
195
43
|
2013 |
121
106
15
|
2013 |
7
7
2
|
2013 |
17
18
|
2013 |
Open access
22
20
|
2013 |
14
14
2
|
2013 |
36
37
4
|
2013 |
Open access
9
9
|
2013 |
28
25
|
2012 |
Open access
12
2
|
2012 |
34
33
6
|
2012 |
30
24
8
|
2012 |
18
18
|
2012 |
Open access
32
31
5
|
2012 |
2
2
4
|
2011 |
Open access
20
18
|
2011 |
26
27
|
2011 |
|
2011 |
9
9
3
|
2011 |
Open access
7
7
|
2008 |
25
25
|
2008 |
12
10
|
Research
External engagement & recognition
Organisation | Country |
---|---|
Australian National University | AUSTRALIA |
Baker Heart and Diabetes Institute | AUSTRALIA |
Beker Pharmaceuticals General Business Plc | ETHIOPIA |
Bristol-Myers Squibb, US | AUSTRALIA |
Centre for Eye Research Australia Ltd | AUSTRALIA |
Centre for Translational Physiology | NEW ZEALAND |
Concord Hospital | UNITED STATES |
Flinders Centre for Innovation in Cancer | AUSTRALIA |
Flinders Medical Centre | AUSTRALIA |
Flinders University | AUSTRALIA |
Greenslopes Private Hospital | AUSTRALIA |
Jimma University | ETHIOPIA |
Karolinska Institute | SWEDEN |
King Saud University | SAUDI ARABIA |
Macquarie University | AUSTRALIA |
Mahidol University | THAILAND |
Modbury Hospital | AUSTRALIA |
Monash Medical Centre | AUSTRALIA |
Monash University | AUSTRALIA |
Murdoch University | AUSTRALIA |
National Institute of Advanced Industrial Science and Technology | JAPAN |
Princess Alexandra Hospital | AUSTRALIA |
Private Individual | AUSTRALIA |
Projections Research | UNITED STATES |
Queen Elizabeth Hospital | AUSTRALIA |
Queensland University of Technology | AUSTRALIA |
Repatriation General Hospital | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Hobart Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
South Australian Health and Medical Research Institute (SAHMRI) | AUSTRALIA |
Stockholm University | SWEDEN |
Suwabus Bessouchi | JAPAN |
The Alfred Hospital | AUSTRALIA |
The Hospital for Sick Children | UNITED STATES |
Tokushima Bunri University | JAPAN |
Univeristy of Toronto | CANADA |
University of Adelaide | AUSTRALIA |
University of Canberra | AUSTRALIA |
University of Manchester | UNITED KINGDOM |
University of Otago | NEW ZEALAND |
University of Sheffield | UNITED KINGDOM |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Tasmania | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Toronto | CANADA |
University of Western Australia | AUSTRALIA |
University of Wollongong | AUSTRALIA |
Watkins Medical Centre | AUSTRALIA |
Westmead Hospital | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
MemberAustralian Society of Clinical Immunology and Allergy (ASCIA) |
2017 |
MemberAustralasian Pharmaceutical Sciences Association (APSA) |
2017 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
A computational approach to improve the prediction of fraction unbound to enhance pharmacokinetic (PK) and biopharmaceutic models | Current |
Assessment of adherence and assessing drug concentration effect relationships in patients with rheumatoid arthritis and scleroderma. | Current |
Comparison of different methods to assess adherence to weekly methotrexate and hydroxychloroquine | Current |
Detecting biomarkers of fetal cardiac damage | Current |
Developing strategies to promote the use of treat to target strategies with conventional synthetic disease modifying anti-rheumatic drugs in patients with early rheumatoid arthritis | Current |
Development of ex vivo models to predict the efficacy of disease modifying agents in rheumatoid arthritis | Current |
Emerging role of pharmacist in preadmission clinics in prevention of postoperative delirium | Current |
Novel methods of analysis and pharmacokinetics of viper venom components in human plasma | Current |
Opioid prescribing in older patients; pharmacoepidemiology and pharmacokinetics | Current |
Personalized-treatment strategies of methotrexate in rheumatoid arthritis patients | Current |
Population variability of the omega-3 index and its relevance to chronic inflammatory disease states | Current |
Proteomic Study of Hepatitis C virus by LC Tandem Mass Spectrometry | Current |
Assessing patterns and appropriateness of prescription of medications in elderly patients admitted to South Australian Hospitals | Completed |
Development and feasibility of a patient-centred deprescribing process | Completed |
Fetal and maternal drug metabolism in complicated pregnancies | Completed |
Individualisation of leflunomide dosing in rheumatoid arthritis patients | Completed |
Interaction between a suboptimal intrauterine environment and maternal drug use on drug metabolism in the offspring | Completed |
Investigating pharmacometric approaches to individualised medicine in autoimmune diseases | Completed |
The role of adherence of physician to treatment strategies and patient to medications in rheumatoid arthritis | Completed |
The role of haptenation in penicillin and cephalosporin allergy | Completed |